L. Clarson

First name
L.
Last name
Clarson
Bajpai, R., Partington, R., Muller, S., Forrester, H., Mallen, C. D., Clarson, L., et al. (2024). Prognostic factors for colchicine prophylaxis-related adverse events when initiating allopurinol for gout: retrospective cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keae229
View
Jordan, K. P., Rathod-Mistry, T., van der Windt, D. A., Bailey, J., Chen, Y., Clarson, L., et al. (2023). Determining cardiovascular risk in patients with unattributed chest pain in UK primary care: an electronic health record study. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwad055
View
Jordan, K. P., Rathod-Mistry, T., Bailey, J., Chen, Y., Clarson, L., Denaxas, S., et al. (2022). Long-Term Cardiovascular Risk and Management of Patients Recorded in Primary Care With Unattributed Chest Pain: An Electronic Health Record Study. J Am Heart Assoc, 11, e023146. http://doi.org/10.1161/jaha.121.023146
View
Roughley, M., Sultan, A. A., Clarson, L., Muller, S., Whittle, R., Belcher, J., et al. (2018). Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Res Ther. http://doi.org/10.1186/s13075-018-1746-1
View
Sultan, A. A., Muller, S., Whittle, R., Roddy, E., Mallen, C., & Clarson, L. (2019). Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy. Cmaj. http://doi.org/10.1503/cmaj.180717
View